BioXcel Therapeutics to Participate in Three Upcoming Healthcare Investor Conferences

NEXT STORY
ContraFect Announces Multiple Publications on Exebacase, Including First Manuscript on Local Administration of Lysin for Potential Treatment of Prosthetic Joint Infections
PREV STORY
Emergent BioSolutions Announces Positive Two-Year Persistence Data From Phase 2 Study Evaluating CHIKV VLP, the Company’s Chikungunya Virus Virus-Like Particle Vaccine Candidate
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Surface Oncology to Participate in 40th Annual Goldman Sachs Global Healthcare Conference

author_avatar
NASDAQ Market News

Signature Resources Launches New Website, Moon Patrol Corporate Video & VRIFY Online Corporate Presentation

author_avatar
NASDAQ Market News

Beyond Air® Reports Positive Interim Results for LungFit® GO Pilot Study Using High Concentration Inhaled Nitric Oxide Self-Administered, At-Home for Nontuberculous Mycobacterial Lung Disease

author_avatar
NASDAQ Market News